REFRACTORY CHOLANGIOCARCINOMA

Clinical trials for REFRACTORY CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New pill tested to fight tough bile duct cancer

Disease control Terminated

This early-stage study aimed to find a safe dose and test the initial effects of a new oral drug called NXP800 for patients with advanced bile duct cancer (cholangiocarcinoma) that had spread or stopped responding to standard treatments. The drug works by blocking a specific path…

Matched conditions: REFRACTORY CHOLANGIOCARCINOMA

Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

REFRACTORY CHOLANGIOCARCINOMA

Get alerted when new REFRACTORY CHOLANGIOCARCINOMA trials appear

New pill tested to fight tough bile duct cancer